Search clinical trials for: Valganiclovir

Total 121 results

National Institute of Allergy and Infectious Diseases...

Completed

CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

Cytomegalovirus Infection

United States
National Institutes of Health Clinical Center (CC)

Completed

Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients

Kidney Trasplant

United States
Hospital Universitari de Bellvitge
Instituto de Salud Carlos III; Spanish Society of Cardiology

Recruiting

Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response (ELISPOT-TC)

CMV Infection | Heart Transplant Infection

Spain
National Institute of Allergy and Infectious Diseases...

Completed

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

Cytomegalovirus Infection

United Kingdom, United States
Medical University of South Carolina
Takeda

Recruiting

Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients

CMV | Transplant Complication

United States
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Terminated

Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy (CYTOVEDO)

Ulcerative Colitis, Unspecified

France
Chimerix

Terminated

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus

Kidney Transplant Infection | Cytomegalovirus Disease

United States
Dr. Ann C.T.M. Vossen
Leiden University Medical Center; Stichting Nuts Ohra

Terminated

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial (CONCERT)

Sensorineural Hearing Loss | Congenital Cytomegalovirus Infection

Netherlands
National Cancer Institute (NCI)

Completed

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Castleman Disease | Multicentric Castleman Disease | Giant Lymph Node Hyperplasia

United States
Chimerix

Terminated

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease (SUSTAIN)

Cytomegalovirus Disease

United States
M.D. Anderson Cancer Center
Roche Pharma AG

Completed

Oral Valganciclovir Versus Valacyclovir

Leukemia | Chronic Lymphocytic Leukemia

United States
Viracta Therapeutics, Inc.

Completed

Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV-Associated Lymphoid Malignancies

Lymphoproliferative Disorders | Epstein-Barr Virus Associated Lymphoma

United States, Brazil
Shire
Takeda Development Center Americas, Inc.

Completed

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Cytomegalovirus (CMV)

United States, China, Spain, Belgium, Australia, Germany, Italy, Canada, France, Croatia, Singapore, United Kingdom, New Zealand, Korea, Republic of, Russian Federation, Poland, Austria, Greece, Switzerland, Czechia, Hungary, Israel, Turk...
Dr. Ann C.T.M. Vossen
Leiden University Medical Center; Stichting Nuts Ohra

Completed

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment (CONCERT 2)

Sensorineural Hearing Loss | Congenital Cytomegalovirus Infection

Netherlands
Rznomics, Inc.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Glioblastoma
Medical University of South Carolina
CSL Behring

Completed

Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection

Cytomegalovirus Disease

United States
GlaxoSmithKline

Completed

Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

Varicella
University of California, San Francisco
Khon Kaen University; King Chulalongkorn Memorial Hospital; Huang Pacific Foundation

Recruiting

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes (STACCATO)

Cytomegalovirus Anterior Uveitis

Thailand, United States
GlaxoSmithKline

Completed

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

Herpes Genitalis

United States, Canada, Brazil, Argentina, Chile
Maruho Co., Ltd.

Completed

Phase III Study of ASP2151 in Herpes Zoster Patients

Herpes Zoster

Japan
GlaxoSmithKline

Completed

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

Infections, Herpesviridae

United States
GlaxoSmithKline

Completed

Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets

Virus Diseases
GlaxoSmithKline

Completed

A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children

Herpes Simplex

United States, Chile, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

Herpes Simplex

United States
HemaQuest Pharmaceuticals Inc.

Terminated

Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders

Lymphoproliferative Disorders | Lymphoid Malignancies

United States
National Institute of Allergy and Infectious Diseases...

Completed

Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections

Cytomegalovirus Infection

United Kingdom, United States
GlaxoSmithKline

Completed

Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

Genital Herpes
University of Lausanne Hospitals

Completed

Cell-mediated Immunity for Prevention of CMV Disease

Cytomegalovirus Infections

Switzerland
Mepha Ltd.

Completed

Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in Adults

Urinary Tract Infection

Mexico
Hospital Universitario 12 de Octubre
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Active, not recruiting

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia (EMPIRICAL)

Pneumonia | HIV/AIDS | Tuberculosis | Cytomegalovirus Infections

Zimbabwe, France, Côte D'Ivoire, Italy, Malawi, Mozambique, Netherlands, Spain, Uganda, United Kingdom, Zambia
GlaxoSmithKline

Completed

Evaluation Of Valaciclovir In Patients With Chickenpox

Varicella
National Institute of Cancerología
Instituto Nacional de Enfermedades Respiratorias

Completed

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Kaposi Sarcoma | Human Immunodeficiency Virus | Immune Reconstitution Syndrome

Mexico
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine (ISCHEMIA)

Delayed Cerebral Ischemia | Aneurysmal Subarachnoid Hemorrhage

Netherlands
Belfast Health and Social Care Trust
Queen's University, Belfast; Northern Ireland Clinical Trials Unit

Terminated

Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial (EViSCO)

COPD | EBV

United Kingdom
University Medical Center Groningen
Stanley Medical Research Institute

Completed

To Rescue Cognition With Valaciclovir

Schizophrenia | Psychosis

Netherlands
Hugo Lovheim

Completed

Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease (VALZ-Pilot)

Alzheimer Disease | Herpes Simplex | Mild Cognitive Impairment

Sweden
Professor Lorraine Harper
Wellcome Trust

Unknown

CMV Modulation of the Immune System in ANCA-associated Vasculitis (CANVAS)

ANCA Associated Vasculitis | CMV Infection

United Kingdom
Vanderbilt University Medical Center
Genentech, Inc.

Completed

A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United States
Albert Park
Genentech, Inc.; National Institute on Deafness and Other Communication Disorders...

Active, not recruiting

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants (ValEAR)

Cmv Congenital | CMV | Congenital Cmv | SNHL | Sensorineural Hearing Loss

United States
Hoffmann-La Roche

Completed

A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

HIV Infections | Cytomegalovirus Retinitis

United States, Canada
National Institute of Allergy and Infectious Diseases...

Completed

Valganciclovir in Congenital CMV Infants

Cytomegalovirus Infections

United States
Washington University School of Medicine

Terminated

Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant

Cytomegalovirus Infections

United States
University Medical Center Groningen

Unknown

(Val)Ganciclovir TDM in Transplant Recipients

Cytomegalovirus Infections

Netherlands
Bausch & Lomb Incorporated

Completed

Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant

Uveitis, Posterior

United States
NYU Langone Health
Viracor Eurofins

Not yet recruiting

CMV Immunity Monitoring in Lung Transplant Recipients

Lung Transplant; Complications

United States
University College, London

Completed

Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

Viraemia

United Kingdom
Maimónides Biomedical Research Institute of Córdoba
Instituto de Salud Carlos III

Completed

Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients. (CYTOCOR)

Cytomegalovirus Infections | Transplantation Infection

Spain
Bial - Portela C S.A.

Completed

Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone

Parkinson Disease

Germany
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections (LUCY-1)

Cytomegalovirus Infection

France
First Affiliated Hospital Xi'an Jiaotong University

Unknown

The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population

Renal Transplant Recipients

China

Search clinical trials for: Valganiclovir

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations